Home›Companies›Biotech & Pharma›MicroPure Genomics

MicroPure Genomics, Inc.

Develops instruments that prepare genomic samples for research and healthcare.

Updated Nov 10, 2026·Latest SEC filing Jul 8, 2026·Suggest an edit

About MicroPure Genomics

MicroPure Genomics is a private company based in San Diego, California. It has reported $675,000 raised in one offering on Form D since July 2026. Its chief executive is Ryan Montes.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 20, 2026Jul 8, 2026$675,000of $2.0M target11$61,364Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on MicroPure Genomics's Form D filed Jul 8, 2026.

Jason Butler
Jason Butler
CTO & Co-Founder, director
Ryan Montes
Ryan Montes
CEO & Co-Founder, director

Sources

  1. SECMicroPure Genomics, Inc. filing history
  2. ResearchUniversity of Florida Department of Chemical Engineering